USFDA informs Biocon, Mylan of deferred action on biosimilar license plea ...Middle East

Biocon said its arm, Biocon Biologics, and Mylan have been informed by the USFDA of a deferred action on the biologics license application for a biosimilar to drug Avastin

Hence then, the article about usfda informs biocon mylan of deferred action on biosimilar license plea was published today ( Friday 25/12/2020 - 11:30 AM ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( USFDA informs Biocon, Mylan of deferred action on biosimilar license plea )

Also on site :

• The Invisible Energy Crisis Threatening to Derail the AI Boom
• Shield AI awarded U.S. Air Force production contract for Collaborative Combat Aircraft mission autonomy
• Die Hon Hai Technology Group (Foxconn) baut bei der VivaTech ihre weltweite Führungsrolle im Bereich KI-Fabriken und KI-Infrastruktur weiter aus